PharmaSource Podcast

Vitema  is a fast-growing Contract Development and Manufacturing Organization (CDMO) based in Sibiu, Romania. With one of the largest GMP-certified pharmaceutical manufacturing facilities in Europe, new management team and assets worth over €100 million, they have ambitious goals. Ahead of  CDMO Live  we spoke to  Diana Serban , the Head of Commercial and Business Development at Vitema. Diana desc...

Aizon  is on a mission to integrate modern computing into the complex arena of GMP manufacturing processes in life sciences. In the latest episode of the PharmaSource podcast we sat down with  Claus Abildgren , Chief Revenue Officer at Aizon, and  David O’Gara , Strategic Advisor to Aizon to understand how artificial intelligence can make an impact on manufacturing in the highly-regulated industry...

“ The biggest challenge for scientists to understand that it’s not just your expertise that people are buying, it’s your ability to connect with their problem.”   Dr. Jeff Kiplinger , a former scientific leader at Pfizer, founded, scaled and sold Averica Discovery Services, a Boston-based CRO specializing in early-stage contract research and analytical development. Now best-selling of author “Expe...

Pfizer CentreOne  is an “altogether different kind of CDMO”. Unlike a pure play contract development and manufacturing partner, they don’t own their own plants and pharmaceutical development centres. Instead their customers can leverage the wealth of expertise and state-of-the-art facilities Pfizer possesses. Ahead of  CDMO Live 2024  we sat down with  Tom Wilson , VP of Global Contract Manufactur...

“Good quality supplier data is the backbone of procurement,” says Lana Radosevic,  Global Supplier Lead in Procurement Excellence at Astellas In her role in Procurement Excellence, Lana Radosevic’s primary focus is on improving supplier data quality across all SaaS systems used by Global Procurement and integrating supplier data.  In the latest episode of the PharmaSource podcast she explains the...

Terumo is a mid to large size-global medical device company based in Japan, with offices in over 160 countries around the world and over 50,000 products and services. The  Terumo Pharmaceutical Solutions Division , also known as ‘PSD’, is a leading manufacturer of injectable solutions – including primary container, infusion therapy devices, general drug delivery devices – and contract development...

Grand River Aseptic Manufacturing  (GRAM), as the name suggests, is a leading sterile injectable drug manufacturer based in Grand Rapids, Michigan. Following significant investments in state-of-the-art facilities and equipment, GRAM has capacity for fill-finish biologics, small molecules, and vaccines. Ahead of CDMO Live , we had the opportunity to sit down with David Powell, Vice President of Bus...

Bayer Consumer Health heavily relies on contract development and manufacturing, maintaining a network of nearly 200 contract manufacturers that account for approximately half of their global sales. This is set to change with the Project Martini initiative, which aims to significantly “shake up” and consolidate their network of contract manufacturers. Speaking ahead of CDMO Live, David Buhmann , Vi...

Onyx Scientific is a Contract Development and Manufacturing Organization (CDMO) that specializes in process R&D, non-GMP scale-up, and GMP manufacture for clinical trials and commercial applications. With facilities in the UK and US, their dedicated teams in chemistry, solid-state and analytical chemistry guide small molecule Active Pharmaceutical Ingredient (API) products through development...

“Contract negotiations are often perceived as a POWER GAME but in reality, it has to be a collaboration.” says Dr Roxana Timmermans In the latest episode of the PharmaSource podcast, Dr. Timmermans explains why contract negotiations are of critical importance in pharma outsourcing and shares her framework for success. “Proper negotiation, is the foundation of a strong partnership. In the highly re...

While pharmaceutical companies have proven the return on investing in digital at early stages of drug discovery, manufacturing has been slower to embrace digital transformation. To understand how pharma R&D and manufacturing can unlock more business value through adopting digital tools and technologies, we speak to Digital CMC consultant Mark Buswell . Mark is a chemical engineer by training,...

In 2024 the world of Contract Development & Manufacturing has been going through a period of major upheaval. Since the start of the year, every day have been significant acquisitions or investments in the CDMO space. In the United States there are highly significant legislative changes working their way through Congress which will re-define the industry. Ahead of his talk at  CDMO Live , we sp...

Alcami, a contract development and manufacturing organization headquartered in North Carolina, is in a period of high growth. With more than 50 years of experience advancing products through every stage of the development lifecycle, Alcami serves pharmaceutical and biotech companies of all sizes for small molecules and biologics – primarily in the United States. Ahead of  CDMO Live , we sat down w...

Supplier Relationship Management is a ‘systematic approach to evaluating vendors that supply goods, materials, and services to an organization. It involves determining each supplier’s contribution to success and developing strategies to improve their performance’. Anirban Mukherjee , Head of Procurement at Immunovant, argues that while Supplier Relationship Management (SRM) is crucial for achievin...

On International Women's Day 2024, the PharmaSource community hosted an important debate, asking "how can the biopharma industry do better at supporting and elevating women into leadership roles?" The panel included Elke Geysen, SVP Head of Global Procurement and External Supply at Grünenthal Group, Roxana Timmermans PhD, Supply Chain Procurement & Global Alliances Leader and was...

In today’s episode we talk about real-world applications of AI and Pharma 4.0 and how it can make a difference to Pharma Manufacturing. Our guest is Daniel O’Mahoney a Digital Transformation consultant in the Life Sciences, working for Körber Pharma, and Part-time Lecturer in Pharma 4.0 Bio-Industry 4.0 NIBRT National Institute for Bioprocessing Research and Training In this interview, we talk abo...

“Honesty is between sponsor and contract manufacturer is essential,” says Philip Coetzee , Director CMO Management for Daiichi Sankyo Europe. “Be honest. I find it very difficult to work with someone who tells me ‘half-truths and whole lies’. I’d rather someone say – ‘someone messed up’ than try to hide it. It’s human. Things happen.” In the latest episode of PharmaSource podcast Philip talks abou...

Bernardo Estupiñán has a career spanning chemistry and business development, and now working as a consultant to guide companies developing new biopharmaceuticals through contract manufacturing In this interview we talk about his advice for how biotechs can successfully navigate the contract manufacturing landscape in order to bring new products into the clinic on budget. “The biggest challenge? Mo...

“Sustainability is giving more than you take.” Fred Turco is Vice President of Enterprise Indirects and Sustainable Sourcing Lead at Pfizer. In the latest episode of the PharmaSource podcast he explains how the company is making progress towards its targets by collaborating with suppliers. The Enterprise Indirects team Fred manages operates across 85 countries and 300 facilities managing the major...

“Small to midsize biotechs are the future of the biopharma industry” says Stefan Verhayden , Global Vice President of GX biological solutions and syringes at Gerresheimer. Stefan leads the company’s packaging and drug delivery services in the fast growing biopharma segment. “They are the ones develop molecules that then afterwards, either go commercial to themselves or are being picked up by the b...

AlfaSigma, the Italian pharmaceutical company, has undergone significant changes with three acquisitions in the last 12 months. At the same time Fabio Russo, who recently joined as the Chief Procurement Officer, is pioneering a transformation of the procurement function. Leveraging his background in management consulting, he is introducing a new target operating model that repositions the procurem...

Grifols Partnership , is a contract development and manufacturer (CDMO) focused on added-value injectable products for small molecules, headquartered in Barcelona, Spain. In this episode of the PharmaSource podcast, Marga Viñes Senior Business Development Manager for Grifols contract manufacturing, explains the drug development and manufacturing services that they offer to customers. “Grifols is m...

Negotiating for yourself can be challenging. If you are a woman there are still implicit biases you might face, and self-doubt that can undermine your confidence and performance. Yet, knowing your worth and negotiating for it is crucial for advancing your career, increasing your income, and achieving your goals. In the latest Women in Pharma Procurement meetup, our expert panel shared best practic...

Clinical research is a vital part of developing new treatments and cures for diseases. But it is also a complex and challenging process that faces many obstacles and inefficiencies. Scott Schliebner is a Clinical Development Executive and advisor to early-stage biotech companies, helping them to design and execute clinical trials. In the latest episode of the PharmaSource podcast, he shares his in...

Malik Akhtar is Vice President at Bayer Consumer Health Division, where he oversees a network of 5000 suppliers, including direct materials, APIs, and 180 contract manufacturers. Speaking on the PharmaSource Podcast, Malik explains the “Three C” procurement strategy which defines the areas of greatest focus for Bayer in 2024 and beyond: Cost Containment Cash-Flow improvement CO2 De-carbonisation R...